Skip to content

A study on the preliminary effects of different oxygen inhalation modes on the adaptation of individuals entering high-altitude areas rapidly

Clinical study on the application effect of different oxygen inhalation modes in low oxygen acclimatization of people entering high altitude rapidly

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105548
Enrollment
Unknown
Registered
2025-07-07
Start date
2025-06-07
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute altitude sickness

Interventions

Non oxygen group:Non oxygen
Low flow oxygen inhalation group:2L/min flow rate oxygen inhalation, 4 hours/day, lasting for 1 week
High flow oxygen inhalation group:4L/min flow rate oxygen inhalation, 4 hours/day, lasting for 1 week
Ladder deoxygenation group:Oxygen inhalation at a flow rate of 4L/min. Check every half hour. If the patients breathing is less than 20 beats per minute, pulse is less than 120 beats per minute, oxyge

Sponsors

General Hospital of Xizang Military Command of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Participants enter high-altitude areas (above 3000 meters above sea level) from plain areas (below 200 meters above sea level) within one week; 2. Participants need to live, work, or engage in high-intensity physical activities in high-altitude environments and have a need for high-altitude adaptation; 3. No serious heart, lung, circulatory, or nervous system diseases; 4. Within the age range of 18 to 65 years old; 5. Participants need to understand the research purpose, process, and potential risks, be willing to participate in the research and practice of high-altitude ladder deoxygenation therapy, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Serious illness: The candidate suffers from severe heart, lung, or circulatory system diseases and cannot withstand the physiological challenges brought by high-altitude stepwise deoxygenation therapy; 2. Pregnant women or participants with severe psychological disorders; 3. Having traveled to or resided in the plateau for a long time.

Design outcomes

Primary

MeasureTime frame
Preliminary habituation rate;

Secondary

MeasureTime frame
Oxygen consumption;High altitude sickness symptom score;Incidence of severe acute altitude sickness;Incidence of acute altitude sickness;

Countries

China

Contacts

Public ContactBowen Wang

General Hospital of Xizang Military Command of the Chinese People's Liberation Army

1491867642@qq.com+86 136 5951 6572

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026